INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
Sustainability in Drug Delivery
171
Issue No #171 April/May 2025
May 1st, 2025
Download PDF
Issue 171 - Apr/May 2025
Inside the magazine
INTERVIEW
Dr Patrick Anquetil
Portal Instruments
A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors
In this exclusive interview with ONdrugDelivery’s Guy Furness, Dr Patrick Anquetil offers insight into the extensive waste involved in the self-injection market. He explains how pivoting from a model focused on fully disposable devices to reusable electromechanical autoinjectors could offer a more sustainable and cost-effective path forward.
SUSTAINABILITY
Edwin Van der Heul
ALBIS Distribution
SUSTAINABILITY IN DRUG DELIVERY: INNOVATIONS IN PLASTIC COMPONENTS AND CIRCULAR DESIGN
Edwin van der Heul considers the increasing regulatory pressure on manufacturers to deliver sustainable solutions in the medical device industry. This article explores these innovations and their impact on the future of drug delivery devices.
SUSTAINABILITY
Ann Cartwright
PCI Pharma Services
FIVE CRUCIAL COMPONENTS OF A SUCCESSFUL SUSTAINABLE PROCUREMENT STRATEGY
Ann Cartwright and Tim Hansen explain the five key components of PCI's sustainable procurement strategy to increase efficiency, meet regulatory demands and support business resilience and sustainability in the long term.
SUSTAINABILITY
Stevanato Group
UNDERSTANDING PATIENT PREFERENCES FOR SUSTAINABLE ON-BODY DELIVERY SYSTEMS
Stevanato Group examines how semi-reusable, modular designs like its Vertiva
10 mL on-body delivery system can reconcile patient demands for ease of use with growing expectations for sustainability, sharing new UK preference data and lifecycle analysis that reveal significant waste and emissions reductions.
SUSTAINABILITY
Lorenzo Biasio
Ypsomed
SUSTAINABLE GLP-1 DRUG DELIVERY: FUTURE-PROOFING THERAPY ADMINISTRATION FOR OBESITY AND BEYOND
Lorenzo Biasio and Gloria Skibba discuss the integration of Ypsomed’s Net Zero Program into its self-injection platforms. With the evolution of GLP-1 therapies and the exploration of higher-dose formulations, the demand for higher-volume autoinjectors is increasing; this article explains how Ypsomed has also applied its sustainability principles to larger-volume delivery.
INTERVIEW
Chris Baron
Aptar Pharma
The Transition to Lower-Global-Warming-Potential Propellants in pMDIs
Aptar Pharma’s Chris Baron discusses how the company has developed a new metering valve technology platform – ZEN30 Futurity™ – that is compatible with leading lower-GWP propellants. By collaborating with drug developers, regulators and the pMDI supply chain, Aptar Pharma aims to support the reduction of the CO
2
footprint of pMDIs while ensuring that the pharmaceutical industry’s strict regulatory requirements are met or exceeded.
EXPERT VIEW
Jack Eaton
THE PFAS PROBLEM: IMPROVING SUSTAINABILITY WITH NONWOVEN INNOVATION
Jack Eaton considers the current landscape for drug delivery and packaging, and how developments and research in nonwoven and fibrous materials can help businesses address the problem of per- and polyfluoroalkyl substances.
EXPERT VIEW
Sas Maheswaran
AI, DATA AND PARTNERSHIPS: THE BUILDING BLOCKS FOR MORE SUSTAINABLE CLINICAL TRIALS
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable – both financially and environmentally.
EARLY INSIGHT
Julian Lotz
BIOVOX
BIOPLASTICS IN DRUG DELIVERY: GETTING RID OF CRITICAL SUBSTANCES AND CARBON EMISSIONS
Julian Lotz introduces bio-based solutions for drug delivery devices, excelling in quality while meeting upcoming sustainability regulations, and explores the future of bioplastics in the healthcare sector.
SUSTAINABILITY
Luca Chiochia
ELIX Polymers
IMPORTANCE OF PRE-COLOURED ABS IN INHALATION MEDICAL DEVICES
Luca Chiochia discusses the vital role of coloured plastics in medical devices and how the use of pre-coloured, pre-tested solutions can provide not only a significantly reduced regulatory burden for device developers and manufacturers but also a higher quality end product, going on to explain how the company is approaching the critical subject of producing more sustainable polymers.
Top
